✦ LIBER ✦

Mycophenolate mofetil therapy for children with intractable nephrotic syndrome

✍ Scribed by MITSURU OKADA; KEISUKE SUGIMOTO; KAZURO YAGI; HIDEHIKO YANAGIDA; NOBUTADA TABATA; TSUKASA TAKEMURA

Book ID: 108971400
Publisher: John Wiley and Sons
Year: 2007
Tongue: English
Weight: 109 KB
Volume: 49
Category: Article
ISSN: 1328-8067
DOI: 10.1111/j.1442-200x.2007.02487.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Mycophenolate mofetil therapy for childr

Mycophenolate mofetil therapy for children with steroid-resistant nephrotic syndrome

✍ Zhihui Li; Cuirong Duan; Jinhua He; Tianhui Wu; Mai Xun; Yi Zhang; Yan Yin 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 112 KB

Mycophenolate mofetil in children with s

Mycophenolate mofetil in children with steroid/cyclophosphamide-resistant nephrotic syndrome

✍ Valderez Raposo de Mello; Maira Tinte Rodrigues; Tais Helena Mastrocinque; Simon 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 138 KB

Frequently relapsing nephrotic syndrome:

Frequently relapsing nephrotic syndrome: treatment with mycophenolate mofetil

✍ Jutta Gellermann; Uwe Querfeld 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 130 KB

Remission of relapsing childhood nephrot

Remission of relapsing childhood nephrotic syndrome with mycophenolate mofetil

✍ M. Chandra; M. Susin; C. Abitbol 📂 Article 📅 2000 🏛 Springer 🌐 English ⚖ 20 KB

Treatment with mycophenolate mofetil and

Treatment with mycophenolate mofetil and prednisolone for steroid-dependent nephrotic syndrome

✍ Kamran Afzal; Arvind Bagga; Shina Menon; Pankaj Hari; Stanley C. Jordan 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 132 KB

Mycophenolate mofetil versus cyclosporin

Mycophenolate mofetil versus cyclosporine for remission maintenance in nephrotic syndrome

✍ Eiske M. Dorresteijn; Joana E. Kist-van Holthe; Elena N. Levtchenko; Jeroen Naut 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 194 KB

We performed a multi-centre randomized controlled trial to compare the efficacy of mycophenolate mofetil (MMF) to that of cyclosporine A (CsA) in treating children with frequently relapsing nephrotic syndrome and biopsy-proven minimal change disease. Of the 31 randomized initially selected patients,